CLINICAL_TRIALS
trial_result
· 2021-12-29
Clinical Trial Update: Efficacy of OC-01 Nasal Spray on Goblet Cell and Meibomian Gland Stimulation [Phase 2]
Summary
Phase 2 trial evaluating OC-01 nasal spray for stimulation of goblet cells and meibomian glands in dry eye disease has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oyster Point Pharma, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-12-29